Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Blood glucose levels are maintained by the balance between glucose uptake by peripheral tissues and glucose secretion by the liver. Gluconeogenesis is strongly stimulated during fasting and is aberrantly activated in diabetes mellitus. Here we show that the transcriptional coactivator PGC-1 is strongly induced in liver in fasting mice and in three mouse models of insulin action deficiency: streptozotocin-induced diabetes, ob/ob genotype and liver insulin-receptor knockout. PGC-1 is induced synergistically in primary liver cultures by cyclic AMP and glucocorticoids. Adenoviral-mediated expression of PGC-1 in hepatocytes in culture or in vivo strongly activates an entire programme of key gluconeogenic enzymes, including phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase, leading to increased glucose output. Full transcriptional activation of the PEPCK promoter requires coactivation of the glucocorticoid receptor and the liver-enriched transcription factor HNF-4alpha (hepatic nuclear factor-4alpha) by PGC-1. These results implicate PGC-1 as a key modulator of hepatic gluconeogenesis and as a central target of the insulin-cAMP axis in liver.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hepatic gluconeogenesis is promoted by the PKA-mediated phosphorylation of the cAMP response element-binding protein, which in turn upregulates peroxisome proliferator-activated receptor-γ coactivator (PGC)-1.160 Together with the hepatocyte nuclear factor (HNF)-4, PGC-1 induces the transcription of phosphoenolpyruvate carboxykinase,161 which catalyzes the conversion of oxaloacetate into phosphoen”
From Pancreatic regulation of glucose homeostasis. (2016) · cites this paper as [161]
In the citing paper
“Previous work has established that repression of either or both co-activators (PGC-1α or PGC-1β) decreases mitochondrial biogenesis and function, elicits cardiomyopathy and impairs de novo glucose production23-25.”
From Telomere dysfunction induces metabolic and mitochondrial compromise (2011) · cites this paper as [24]
In the citing paper
“In liver PGC-1α is upregulated by fasting and induces a shift in metabolism toward increased glucose output [80].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
In the citing paper
“The metabolic shifts that occur in response to fasting highlight the non-equivalence of PGC-1α function in distinct tissues.”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [80]
Citations
Cites
Wu, Z., Puigserver, P., Andersson, U., Zhang, C., Adelmant, G., Mootha, V., Troy, A., Cinti, S., Lowell, B., Scarpulla, R. C., et al. (1999) · Cell · doi:10.1016/s0092-8674(00)80611-x · Cited by 4,139 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationA Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864 · cited 1×
“We have previously described a coactivator of nuclear receptors and other transcription factors, PGC-1, which has a major role in cellular respiration and adaptive thermogenesis in tissues such as skeletal muscle and brown fa”
BackgroundSelf-citationThe coregulator exchange in transcriptional functions of nuclear receptors
Glass, C. K., & Rosenfeld, M. G. (2000) · Genes & Development · doi:10.1101/gad.14.2.121 · Cited by 2,233
Cho, H., Mu, J., Kim, J. K., Thorvaldsen, J. L., Chu, Q., Crenshaw, E. B., Kaestner, K. H., Bartolomei, M. S., Shulman, G. I., & Birnbaum, M. J. (2001) · Science · doi:10.1126/science.292.5522.1728 · Cited by 1,836
Michael, M. D., Kulkarni, R. N., Postic, C., Previs, S. F., Shulman, G. I., Magnuson, M. A., & Kahn, C. R. (2000) · Molecular Cell · doi:10.1016/s1097-2765(05)00015-8 · Cited by 1,296 · cited 1×
“The liver-specific insulin-receptor knockout (LIRKO) mouse is a unique model of hepato-specific insulin resistance in the liver, and is associated with impaired glucose tolerance and the failure of insulin to suppress hepatic glucose productio”
BackgroundSelf-citationPeroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
Lehman, J. J., Barger, P. M., Kovacs, A., Saffitz, J. E., Medeiros, D. M., & Kelly, D. P. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10268 · Cited by 1,285
Vega, R. B., Huss, J. M., & Kelly, D. P. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.5.1868-1876.2000 · Cited by 1,195 · cited 1×
“This region of PGC-1 has previously been shown to mediate ligand-dependent interactions with the activation function-2 (AF-2) domains of several nuclear receptors, including oestrogen receptor-α (ERα), peroxisome proliferator-activated receptor-α (PPARα) and glucocorticoid recepto”
BackgroundMolecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865 · cited 1×
“Glycogenolysis occurs more rapidly, beginning within 2–3 h after a meal in humans, but gluconeogenesis assumes a much greater importance with prolonged fastin”
BackgroundSelf-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“PGC-1 coactivates HNF-4α and the glucocorticoid receptor The mechanisms underlying the transcriptional activation of the gluconeogenic enzyme PEPCK have been extensively studie”
Background(1997) · Diabetes reviews · Cited by 671
Cited by
Items 501–600 of 1,002
Elevated hepatic expression of H19 long noncoding RNA contributes to diabetic hyperglycemia
Zhang, N., Geng, T., Wang, Z., Zhang, R., Cao, T., Camporez, J. P., Cai, S.-Y., Liu, Y., Dandolo, L., Shulman, G. I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.120304 · Cited by 80
Kim, D., Kim, J. R., Koh, M., Kim, Y. D., Lee, J.-M., Chanda, D., Park, S. B., Min, J., Lee, C., Park, T., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250613 · Cited by 90
Vanin-1 Is a Key Activator for Hepatic Gluconeogenesis
Chen, S., Zhang, W., Tang, C., Tang, X., Liu, L., & Liu, C. (2014) · Diabetes · doi:10.2337/db13-0788 · Cited by 88
“At the molecular level, PGC-1a facilitates the transcriptional activity of the glucocorticoid receptors FOXO1 and hepatocyte nuclear factor-4a (HNF-4a) on the promoter of gluconeogenic genes (9,10).”
BackgroundNuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-specific circadian networks
Qu, M., Duffy, T., Hirota, T., & Kay, S. A. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1816411115 · Cited by 83
Fibroblast Growth Factor 21 As an Emerging Therapeutic Target for Type 2 Diabetes Mellitus
So, W. Y., & Leung, P. S. (2016) · Medicinal Research Reviews · doi:10.1002/med.21390 · Cited by 93
“The engineered FGF21, FGF21(1-171)-WD22, is functionally indistinguishable from native FGF21 in terms of signaling activation, receptor binding specificity, and induction of adipose glucose uptake, but has increased potency with the more tolerant C-terminal modification.”
BackgroundIntercellular: local and systemic actions of skeletal muscle PGC-1s
Correia, J. C., Ferreira, D. M. S., & Ruas, J. L. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2015.03.010 · Cited by 95
Napal, L., Marrero, P. F., & Haro, D. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.09.097 · Cited by 85
Lane, R. H., MacLennan, N. K., Hsu, J. L., Janke, S. M., & Pham, T. D. (2002) · Endocrinology · doi:10.1210/endo.143.7.8898 · Cited by 93
Metformin induces PGC‐1α expression and selectively affects hepatic PGC‐1α functions
Aatsinki, S., Buler, M., Salomäki, H., Koulu, M., Pavek, P., & Hakkola, J. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12585 · Cited by 85
“Metformin selectively affects PGC-1α regulated functions PEPCK is an established target gene of PGC-1α and overexpression of PGC-1α strongly induces PEPCK expression (Yoon et al., 2001).”
BackgroundThe Krüppel-Like Factors and Control of Energy Homeostasis
Hsieh, P. N., Fan, L., Sweet, D. R., & Jain, M. K. (2018) · Endocrine Reviews · doi:10.1210/er.2018-00151 · Cited by 86
Gropler, M. C., Harris, T. E., Hall, A. M., Wolins, N. E., Gross, R. W., Han, X., Chen, Z., & Finck, B. N. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m807882200 · Cited by 88
cAMP-dependent Signaling Regulates the Adipogenic Effect of n-6 Polyunsaturated Fatty Acids
Madsen, L., Pedersen, L. M., Liaset, B., Ma, T., Petersen, R. K., van den Berg, S. A. A., Pan, J., Müller‐Decker, K., Dülsner, E., Kleemann, R., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m707775200 · Cited by 97
Eeckhoute, J., Moerman, E., Bouckenooghe, T., Lukoviak, B., Pattou, F., Formstecher, P., Kerr-Conte, J., Vandewalle, B., & Laine, B. (2003) · Endocrinology · doi:10.1210/en.2002-0024 · Cited by 85
Arany, Z., Wagner, B. K., Ma, Y., Chinsomboon, J., Laznik, D., & Spiegelman, B. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800979105 · Cited by 82
“some side effects, such as induction of gluconeogenesis in the liver (11, 12).”
BackgroundSelf-citationNuclear Mechanisms of Insulin Resistance
Kang, S., Tsai, L. T.-Y., & Rosen, E. D. (2016) · Trends in Cell Biology · doi:10.1016/j.tcb.2016.01.002 · Cited by 88
“PGC-1/ is induced in the liver on fasting, is elevated in models of insulin resistance, and can activate the entire transcriptional profile of gluconeogenesis [82,83].”
BackgroundMicroRNA-214 Suppresses Gluconeogenesis by Targeting Activating Transcriptional Factor 4
Li, K., Zhang, J., Yu, J., Liu, B., Guo, Y., Deng, J., Chen, S., Wang, C., & Guo, F. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.633990 · Cited by 79
“proliferation-activated receptor coactivator 1 (PGC1 ) is a master regulator of the gluconeogenic program in fasting and diabetic states (40).”
BackgroundLiver X receptors in cardiovascular and metabolic disease
Geyeregger, R., Zeyda, M., & Stulnig, T. M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5398-3 · Cited by 92
Identification of C. elegans DAF-12-binding sites, response elements, and target genes
Shostak, Y., Gilst, M. V., Antebi, A., & Yamamoto, K. (2004) · Genes & Development · doi:10.1101/gad.1218504 · Cited by 90
“Indeed, examples of all three of these mechanisms have been described for mam- 2538 GENES & DEVELOPMENT malian IRs (Funder et al. 1988; Yamamoto et al. 1992; Yoon et al. 2001).”
BackgroundCyphert, H. A., Alonge, K. M., Ippagunta, S. M., & Hillgartner, F. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094996 · Cited by 79
“Such a mechanism has been described for the glucagon induction of the gluconeogenic enzymes, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6phosphatase (G6PC) [23], the transcriptional coactivator, peroxisome proliferator-activated receptor-g coactivator-1a (PGC-1a) [24], the cell signaling antagonist, suppres…”
BackgroundMinireview: Genomics Versus Orphan Nuclear Receptors--A Half-Time Report
Willson, T. M. (2002) · Molecular Endocrinology · doi:10.1210/me.16.6.1135 · Cited by 82
Whole body overexpression of PGC-1α has opposite effects on hepatic and muscle insulin sensitivity
Liang, H., Balas, B., Tantiwong, P., Dube, J., Goodpaster, B. H., O'Doherty, R. M., DeFronzo, R. A., Richardson, A., Musi, N., & Ward, W. F. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90292.2008 · Cited by 81
Apolipoprotein A-IV Reduces Hepatic Gluconeogenesis through Nuclear Receptor NR1D1
Li, X., Xu, M., Wang, F., Kohan, A. B., Haas, M. K., Yang, Q., Lou, D., Obici, S., Davidson, W. S., & Tso, P. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.511766 · Cited by 84
“We observed that apoA-IV acts to lower blood glucose and suppress PEPCK and Glc-6-Pase gene expression in the absence of its effect on insulin secretion and in isolated hepatocytes in vitro.”
BackgroundInfluentialThe Roles of Peroxisome Proliferator-Activated Receptors in the Metabolic Syndrome
Mansour, M. M. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00007-7 · Cited by 83
Kuo, M.-S., Zilberfarb, V., Gangneux, N., Christeff, N., & Issad, T. (2008) · Biochimie · doi:10.1016/j.biochi.2008.03.005 · Cited by 84
Cherry, A. D., Suliman, H. B., Bartz, R. R., & Piantadosi, C. A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.512483 · Cited by 86
Yang, J., Kong, X., Martins-Santos, M. E. S., Aleman, G., Chaco, E., Liu, G. E., Wu, S.-Y., Samols, D., Hakimi, P., Chiang, C.-M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.047340 · Cited by 78
Yoon, Y.-S., Lee, M., Ryu, D., Kim, J. H., Ma, H., Seo, W., Kim, Y.-N., Kim, S. S., Lee, C. H., Hunter, T. R., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012665107 · Cited by 80
“It is noteworthy that increased expression of PGC-1α itself is a key for the pathogenesis of hepatic insulin resistance in rodents (16, 17, 20).”
Backgroundp53 promotes the expression of gluconeogenesis-related genes and enhances hepatic glucose production
Goldstein, I., Yizhak, K., Madar, S., Goldfinger, N., Ruppin, E., & Rotter, V. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-9 · Cited by 74
“incubated in glucogenic medium [15] for 24 hours.”
InfluentialNutrient-sensing AgRP neurons relay control of liver autophagy during energy deprivation
Chen, W., Mehlkop, O., Scharn, A., Nolte, H., Klemm, P., Henschke, S., Steuernagel, L., Sotelo-Hitschfeld, T., Kaya, E., Wunderlich, C. M., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.03.019 · Cited by 73
Transcriptional Regulation of Hepatic Fatty Acid Metabolism
Guillou, H., Martin, P. G. P., & Pineau, T. (2008) · Sub-cellular biochemistry/Subcellular biochemistry · doi:10.1007/978-1-4020-8831-5_1 · Cited by 90
“However, as previously mentioned, it might involve PGC1 activation downstream of glucagon and glucocorticoı̈ds (Louet et al., 2002; Yoon et al., 2001) together with low insulin.”
BackgroundDistinct C/EBPα motifs regulate lipogenic and gluconeogenic gene expression in vivo
Pedersen, T. Å., Bereshchenko, O., García-Silva, S., Ermakova, O. V., Kurz, E., Mandrup, S., Porse, B. T., & Nerlov, C. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601563 · Cited by 80
“Analysis of a number of gluconeogenic and The EMBO Journal VOL 26 | NO 4 | 2007 &2007 European Molecular Biology Organization1082 IRE-regulated genes (PEPCK, G6Pc, FBP-1, glucose transpor- ter-2 (GLUT2), glycogen synthase (GS), tyrosine aminotrans- ferase (TAT) and insulin-like growth factor binding protein-1 (IGFBP-1…”
BackgroundInfluentialRegulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
Hernandez, C., Molusky, M., Li, Y., Li, S., & Lin, J. D. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.09.001 · Cited by 79
“In the liver, PGC-1a regulates hepatic fasting response and coordinates key aspects of circadian metabolic rhythms (Lin et al., 2004; Liu et al., 2007; Yoon et al., 2001).”
Transcriptional regulators of hepatic gluconeogenesis
Oh, K., Han, H.-S., Kim, M.-J., & Koo, S. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0018-5 · Cited by 85
Chang, C., & McDonnell, D. P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3221 · Cited by 84
Moreno, M., Lombardi, A., Silvestri, E., Senese, R., Cioffi, F., Goglia, F., Lanni, A., & de Lange, P. (2010) · PPAR Research · doi:10.1155/2010/435689 · Cited by 87
“PGC-1 family members can interact not only with PPARs but also with other members of the nuclear receptor superfamily, such as ERR, LXR, and HNF-4α [62–64], and with distinct transcription factors and regulatory elements, including cAMP response element-binding protein (CREB), the lipogenic transcription factor sterol…”
BackgroundLead (Pb) exposure promotes diabetes in obese rodents
Tyrrell, J. B., Hafida, S., Stemmer, P. M., Adhami, A., & Leff, T. (2016) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2016.10.007 · Cited by 80
The emerging roles of lipids in circadian control
Adamovich, Y., Aviram, R., & Asher, G. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.013 · Cited by 85
“[75], and insulin receptor knockout mice [76].”
BackgroundInsulin resistance and fuel homeostasis: the role of AMP‐activated protein kinase
Hegarty, B. D., Turner, N., Cooney, G. J., & Kraegen, E. W. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01968.x · Cited by 77
“CREB has an additional role to increase the transcription of PGC1a, an important co-activator of GNG gene transcription (Herzig et al. 2001, Yoon et al. 2001).”
BackgroundGlyoxalase system in yeasts: Structure, function, and physiology
Inoue, Y., Maeta, K., & Nomura, W. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.002 · Cited by 79
“In diabetic mice, of which blood and tissues the level of methylglyoxal is high, expressions of genes involved in gluconeogenesis such as phosphoenolpyruvate carboxykinase (PEPCK) are enhanced [58,59].”
BackgroundKim, D., Gang, G., Ryu, D., Koh, M., Kim, Y.-N., Kim, S. S., Park, J., Kim, Y., Sim, T., Lee, I., et al. (2013) · Diabetes · doi:10.2337/db12-0946 · Cited by 79
Requirement of Helix 1 and the AF-2 Domain of the Thyroid Hormone Receptor for Coactivation by PGC-1
Wu, Y., Delerive, P., Chin, W. W., & Burris, T. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110761200 · Cited by 79
An extract of Syzygium aromaticum represses genes encoding hepatic gluconeogenic enzymes
Prasad, R. C., Herzog, B., Boone, B., Sims, L. J., & Waltner-Law, M. E. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.09.024 · Cited by 79
PGC-1α in Disease: Recent Renal Insights into a Versatile Metabolic Regulator
Chambers, J. M., & Wingert, R. A. (2020) · Cells · doi:10.3390/cells9102234 · Cited by 82
“Fasting induces PGC-1α expression in the liver through the activation of p38 mitogen-activated protein kinase (p38), where PGC-1α interacts with transcription factors to enable the body to adapt to nutrient deprivation [3,17,18].”
BackgroundThe diverse role of the PPARγ coactivator 1 family of transcriptional coactivators in cancer
Girnun, G. D. (2012) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2012.01.007 · Cited by 87
The mutations and potential targets of the forkhead transcription factor FOXL2
Moumné, L., Batista, F., Benayoun, B. A., Nallathambi, J., Fellous, M., Sundaresan, P., & Veitia, R. A. (2007) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2007.11.006 · Cited by 83
Laye, M. J., Rector, R. S., Borengasser, S. J., Naples, S. P., Uptergrove, G. M., Ibdah, J. A., Booth, F. W., & Thyfault, J. P. (2009) · Journal of Applied Physiology · doi:10.1152/japplphysiol.91186.2008 · Cited by 77
FoxO1 and HNF-4 Are Involved in Regulation of Hepatic Glucokinase Gene Expression by Resveratrol
Ganjam, G. K., Dimova, E. Y., Unterman, T. G., & Kietzmann, T. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.045260 · Cited by 78
Xu, E., Schwab, M. G., & Marette, A. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9282-4 · Cited by 86
Deng, J., Liu, Y., Duan, Z., Zhu, C., Hui, J., Mi, Y., Ma, P., Ma, X., Fan, D., & Yang, H. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00506 · Cited by 77
Murgiano, L., D’Alessandro, A., Egidi, M. G., Crisà, A., Prosperini, G., Timperio, A. M., Valentini, A., & Zolla, L. (2010) · Journal of Proteome Research · doi:10.1021/pr100693h · Cited by 85
Galbraith, L. C. A., Mui, E. J., Nixon, C., Hedley, A., Strachan, D., Mackay, G., Sumpton, D. P., Sansom, O. J., Leung, H. Y., & Ahmad, I. (2021) · Oncogene · doi:10.1038/s41388-021-01707-7 · Cited by 81
Guével, R. L., Oger, F., Lecorgne, A., Dudášová, Z., Chevance, S., Bondon, A., Baráth, P., Simonneaux, G., & Salbert, G. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.079 · Cited by 78
Guan, M., Qu, L., Tan, W., Chen, L., & Wong, C. (2010) · Hepatology · doi:10.1002/hep.24066 · Cited by 77
“HNF-4a regulates the expression of gluconeogenic genes, including phosphoenolpyruvate carboxykinase (PEPCK)(3) and glucose-6-phosphatase (G6P),(4) through binding to hormone response elements on their promoters and recruiting coactivators such as peroxisome proliferator-activated receptor c coactivator1a (PGC-1a) to t…”
Croce, M. A., Eagon, J. C., LaRiviere, L. L., Korenblat, K., Klein, S., & Finck, B. N. (2007) · Diabetes · doi:10.2337/db07-0480 · Cited by 81
“Conversely, hepatic PGC-1 is increased in rodent models of diabetes (22,23).”
BackgroundYoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Hosono, K., Fujita, K., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-27 · Cited by 80
“Recent evidence also implicates PPARGC1A in the homeostatic control of systemic energy metabolism, and PPARGC1A has been shown to regulate several key hepatic gluconeogenic genes [31-34].”
BackgroundChang, J. S., Fernand, V. E., Zhang, Y., Shin, J., Jun, H., Joshi, Y., & Gettys, T. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.320200 · Cited by 82
Mitochondrial dysfunction in human pathologies
Monsalve, M. (2007) · Frontiers in Bioscience · doi:10.2741/2132 · Cited by 75
Hall, R. K., Wang, X. L., George, L., Koch, S. R., & Granner, D. K. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0307 · Cited by 75
“Likewise, although several transcription factors have been implicated in the regulation of the PEPCK gene by insulin, including FoxO1 (14–18), FoxO3 (19), PGC-1 (20), CBP [cAMP response element (CRE) binding protein-(CREB)-binding protein] (21), and CCAAT/enhancer binding protein (C/EBP ) (22), none of these has been…”
BackgroundSelf-citationJhaveri, R. R., McHutchison, J. G., Patel, K., Qiang, G., & Diehl, A. M. (2008) · The Journal of Infectious Diseases · doi:10.1086/524846 · Cited by 77
“Many meaningful studies of basic metabolic pathways within the liver have been performed in rodent cells [41– 44].”
BackgroundChoi, J. S., Jung, M. H., Park, H. S., & Song, J. (2004) · Nutrition · doi:10.1016/j.nut.2004.08.009 · Cited by 74
Xu, J., Ma, M., & Purcell, W. M. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(03)00089-9 · Cited by 81
Ma, D., Li, S., Lucas, E. K., Cowell, R. M., & Lin, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151688 · Cited by 73
PXR and LXR in Hepatic Steatosis: A New Dog and an Old Dog with New Tricks
Lee, J. H., Zhou, J., & Xie, W. (2008) · Molecular Pharmaceutics · doi:10.1021/mp700121u · Cited by 72
Marinho, R., Ropelle, E. R., Cintra, D. E., de Souza, C. T., da Silva, A. S. R., Bertoli, F. C., Colantonio, E., D’Almeida, V., & Pauli, J. R. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23037 · Cited by 83
“…reduction in PGC-1a expression using different approaches diminished hepatic glucose production, as evaluated by hyperinsulinemic– JOURNAL OF CELLULAR PHYSIOLOGY euglycemic clamp procedures (Herzig et al., 2001; Yoon et al., 2001; Puigserver et al., 2003; Rhee et al., 2003; De Souza et al., 2005).”
MethodSolt, L. A., Banerjee, S., Campbell, S., Kamenecka, T. M., & Burris, T. P. (2015) · Endocrinology · doi:10.1210/en.2014-1677 · Cited by 77
Fang, P., Sun, Y., Gu, X., Shi, M., Bo, P., Zhang, Z., & Bu, L. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153074 · Cited by 74
Song, K.-H., Li, T., & Chiang, J. Y. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513420200 · Cited by 71
CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
Sakai, M., Matsumoto, M., Tujimura, T., Yongheng, C., Noguchi, T., Inagaki, K., Inoue, H., Hosooka, T., Takazawa, K., Kido, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2691 · Cited by 77
Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone
Attia, R. R., Connaughton, S., Boone, L. R., Wang, F., Elam, M. B., Ness, G. C., Cook, G. A., & Park, E. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039081 · Cited by 77
Differential Effects of Krill Oil and Fish Oil on the Hepatic Transcriptome in Mice
Burri, L., Berge, K., Wibrand, K., Berge, R. K., & Barger, J. L. (2011) · Frontiers in Genetics · doi:10.3389/fgene.2011.00045 · Cited by 73
PGC‐1α, a potential therapeutic target against kidney aging
Lee, G., Uddin, M. J., Kim, Y., Ko, M., Yu, I., & Ha, H. (2019) · Aging Cell · doi:10.1111/acel.12994 · Cited by 69
“The overexpression of PGC‐1α in both in vitro hepatocyte cultures and in vivo Wistar rats strongly enhances gluconeogenic enzymes, including phosphoenolpyruvate carboxykin‐ ase (PEPCK) and glucose‐6‐phosphatase, leading to increased glucose levels (Yoon et al., 2001).”
BackgroundA highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells
Charos, A. E., Reed, B. D., Raha, D., Szekely, A. M., Weissman, S. M., & Snyder, M. (2012) · Genome Research · doi:10.1101/gr.127761.111 · Cited by 71
“Numerous studies have identified an important role for PPARGC1A in maintaining blood glucose levels by up-regulating genes involved in gluconeogenesis and the beta-oxidation of fatty acids in the liver (Yoon et al. 2001; Lin et al. 2004).”
BackgroundCaloric restriction and exercise “mimetics”: ready for prime time
Handschin, C. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2015.11.009 · Cited by 72
“Moreover, the boost in cAMP levels upon resveratrol-mediated inhibition of phosphodiesterases not only directly activates SIRT1 in an NAD+-independent manner [44], but also promotes transcription of the PGC-1α gene [45].”
BackgroundRole of Krüppel-like factor 15 in PEPCK gene expression in the liver
Teshigawara, K., Ogawa, W., Mori, T., Matsuki, Y., Watanabe, E., Hiramatsu, R., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.096 · Cited by 76
Silent information regulator, Sirtuin 1, and age‐related diseases
Zeng, L., Chen, R., Liang, F.-X., Tsuchiya, H., Murai, H., Nakahashi, T., Iwai, K., Takahashi, T., Kanda, T., & Morimoto, S. (2009) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2008.00504.x · Cited by 73
mTORC2 controls cancer cell survival by modulating gluconeogenesis
Khan, M. W., Biswas, D., Ghosh, M., Mandloi, S., Chakrabarti, S., & Chakrabarti, P. (2015) · Cell Death Discovery · doi:10.1038/cddiscovery.2015.16 · Cited by 73
Babaknejad, N., Nayeri, H., Hemmati, R., Bahrami, S., & Esmaillzadeh, A. (2018) · Hormone and Metabolic Research · doi:10.1055/a-0623-2909 · Cited by 71
“As previously mentioned, FGF21 up regulates PGC1α, a transcriptional co-activator of the transcriptional activity of PPARα, that regulates the expression of gluconeogenesis genes [53, 54].”
BackgroundSong, K., & Chiang, J. Y. L. (2006) · Hepatology · doi:10.1002/hep.20919 · Cited by 70
Delhon, I., Gutzwiller, S., Morvan, F., Rangwala, S. M., Wyder, L., Evans, G. L., Studer, A., Kneissel, M., & Fournier, B. (2009) · Endocrinology · doi:10.1210/en.2009-0121 · Cited by 73
The Coactivator SRC-1 Is an Essential Coordinator of Hepatic Glucose Production
Louet, J.-F., Chopra, A. R., Sagen, J. V., An, J., York, B., Tannour-Louet, M., Saha, P. K., Stevens, R. D., Wenner, B. R., Ilkayeva, O. R., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.009 · Cited by 69
“As previously described, PGC-1a messenger RNA (mRNA) was increased (Yoon et al., 2001), whereas SRC-2 expression was not changed (Figure 1A).”
Self-citationGentili, S., Morrison, J. L., & McMillen, I. C. (2009) · Biology of Reproduction · doi:10.1095/biolreprod.108.073569 · Cited by 72
Nuclear receptor coregulators as a new paradigm for therapeutic targeting
Hsia, E. Y., Goodson, M. L., Zou, J. X., Privalsky, M. L., & Chen, H.-W. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.016 · Cited by 67
“Liver-specific expression of PGC-1α transgene increased blood glucose and insulin levels in normal non-fasting animals [62], while PGC-1 deficiency in the liver enhanced insulin sensitivity [68].”
BackgroundYap, K. H., Gan, S. Y., Candasamy, M., Tan, S. C., Md, S., Majeed, A. B. A., & Bhattamisra, S. K. (2020) · Biomolecules · doi:10.3390/biom10101360 · Cited by 71
The nuclear bile acid receptor FXR is activated by PGC-1α in a ligand-dependent manner
KANAYA, E., SHIRAKI, T., & JINGAMI, H. (2004) · Biochemical Journal · doi:10.1042/bj20040432 · Cited by 70
Tripathy, S., Torres‐Gonzalez, M., & Jump, D. Β. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006080 · Cited by 75
Liang, H., Habte‐Tsion, H., Ge, X., Ren, M., Xie, J., Miao, L., Zhou, Q., Lin, Y., & Pan, W. (2017) · Scientific Reports · doi:10.1038/s41598-017-06104-3 · Cited by 71
Wu, Y., Chin, W. W., Wang, Y., & Burris, T. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m210910200 · Cited by 66
MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1α and PPARγ
Huang, J., Chou, S.-F., Lee, J.-W., Chen, H.-L., Chen, C., Tao, M., & Shih, C. (2015) · RNA · doi:10.1261/rna.048744.114 · Cited by 72
“In addition to promoting hepatic gluconeogenesis (Yoon et al. 2001), 2004), as well as neurodegenerative diseases (St-Pierre et al. 2006).”
Gambardella, G., Moretti, M. N., Cegli, R. D., Cardone, L., Peron, A., & di Bernardo, D. (2013) · Bioinformatics · doi:10.1093/bioinformatics/btt290 · Cited by 76
Structure and Function of the Glucocorticoid Receptor Ligand Binding Domain
Bledsoe, R. K., Stewart, E. L., & Pearce, K. H. (2004) · Vitamins and hormones · doi:10.1016/s0083-6729(04)68002-2 · Cited by 85
Thulin, P., Rafter, I., Stockling, K., Tomkiewicz, C., Norjavaara, E., Aggerbeck, Μ., Hellmold, H., Ehrenborg, E., Andersson, U., Cotgreave, I. A., et al. (2008) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2008.03.007 · Cited by 71
Henkel, J., Frede, K., Schanze, N., Vogel, H., Schürmann, A., Spruss, A., Bergheim, I., & Püschel, G. P. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.128 · Cited by 69
Hepatocyte nuclear factor 4α regulation of bile acid and drug metabolism
Chiang, J. Y. L. (2009) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425250802707342 · Cited by 76
“HNF4 α interacts with peroxisome proliferator-activated receptor γ co-activator 1α (PGC-1 α ) [23,42] , which is a versatile nuclear receptor co-activator induced during fasting to stimulate gluconeogenesis, lipoprotein, triglyceride, energy and drug metabolism [23,42-48] .”
Molusky, M. M., Li, S., Ma, D., Yu, L., & Lin, J. D. (2012) · Diabetes · doi:10.2337/db11-0970 · Cited by 65
Jang, H., Kim, H., Kim, S., Kim, S., Kim, J.-B., & Lee, Y. (2018) · Food Chemistry · doi:10.1016/j.foodchem.2018.08.010 · Cited by 74
PGC-1 and PERC, coactivators of the estrogen receptor-related receptor γ
Hentschke, M., Süsens, U., & Borgmeyer, U. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02753-5 · Cited by 74
PCAF Improves Glucose Homeostasis by Suppressing the Gluconeogenic Activity of PGC-1α
Sun, C., Wang, M., Liu, X., Luo, L., Li, K., Zhang, S., Wang, Y., Yang, Y., Ding, F., & Gu, X. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.029 · Cited by 67
Ma, T., Liaset, B., Hao, Q., Petersen, R. K., Fjære, E., Ngo, H. T., Lillefosse, H. H., Ringholm, S., Sonne, S. B., Treebak, J. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021647 · Cited by 59
“levels of cAMP and plays a central role in the control of hepatic gluconeogenesis [30–32].”
BackgroundBOUSTEAD, J. N., STADELMAIER, B. T., EEDS, A. M., WIEBE, P. O., SVITEK, C. A., OESER, J. K., & O'BRIEN, R. M. (2003) · Biochemical Journal · doi:10.1042/bj20021382 · Cited by 68
Mitochondria and Oxidative Stress in the Cardiorenal Metabolic Syndrome
Aroor, A. R., Mandavia, C., Ren, J., Sowers, J. R., & Pulakat, L. (2012) · Cardiorenal Medicine · doi:10.1159/000335675 · Cited by 67
Metadata
- Authors
- Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., Newgard, C. B., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- The University of Texas Southwestern Medical Center (US)
- Vanderbilt University (US)
- Joslin Diabetes Center (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2001-09
- Volume
- 413
- Issue
- 6852
- Pages
- 131-138
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1523158326
- Cited by
- 1,821
- References
- 33
- Citations by year
- 2026: 25 · 2025: 28 · 2024: 24 · 2023: 48 · 2022: 48 · 2021: 68 · 2020: 63 · 2019: 74 · 2018: 84 · 2017: 67 · 2016: 78 · 2015: 95 · 2014: 75 · 2013: 98 · 2012: 104
- FWCI
- 23.86
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- PGC-1, hepatic gluconeogenesis, transcriptional coactivator, fasting, insulin resistance, diabetes mellitus, phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, glucocorticoid receptor, HNF4α, cyclic AMP, ob/ob mice, streptozotocin-induced diabetes
- MeSH terms
- Cyclic AMP, Animals, Blood Glucose, Cell Line, Diabetes Mellitus, Experimental, DNA-Binding Proteins, Fasting, Gluconeogenesis, Hormones, Insulin, Liver, Male, Obesity, Phosphoenolpyruvate Carboxykinase (GTP), Phosphoproteins, Receptors, Glucocorticoid, Receptor, Insulin, RNA, Messenger, Transcription Factors, Tumor Cells, Cultured, 3T3 Cells, Rats, Wistar, Mice, Knockout, Response Elements, Amino Acid Motifs, Mice, Rats, Hepatocyte Nuclear Factor 4, Basic Helix-Loop-Helix Leucine Zipper Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.